AC
SYNH

Avestar Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Avestar Capital’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,534
Closed -$396K – 482
2021
Q1 		$396K Sell
4,534
-89
-2% -$6.71K 0.09% 206
2020
Q4 		$315K Buy
+4,623
New +$288K 0.09% 201

Other funds holding SYNH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Avestar Capital's SYNH Position: Q2 2021 in Review

Avestar Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2021, closing a stake of 4,534 shares — an estimated $396K sold.

Avestar Capital first reported a position in SYNH in Q4 2020 and held it in 2 quarters. The position peaked at $396K in Q1 2021. 342 funds tracked by Wall St. Rank hold SYNH as of Q2 2021.

  • Avestar Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2021 after selling out during the quarter.
  • Avestar Capital sold 4,534 Syneos Health, Inc. Class A Common Stock shares in Q2 2021, an estimated $396K.
  • Avestar Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2020 and held it in 2 quarters.
  • Avestar Capital's Syneos Health, Inc. Class A Common Stock position peaked at $396K in Q1 2021.
  • 342 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2021.

Based on Avestar Capital's 13F filing for Q2 2021, filed 3 Aug 2021.